SG126893A1 - Method for the identification of epitopes related to immunogenicity in biopharmaceuticals - Google Patents

Method for the identification of epitopes related to immunogenicity in biopharmaceuticals

Info

Publication number
SG126893A1
SG126893A1 SG200602630A SG200602630A SG126893A1 SG 126893 A1 SG126893 A1 SG 126893A1 SG 200602630 A SG200602630 A SG 200602630A SG 200602630 A SG200602630 A SG 200602630A SG 126893 A1 SG126893 A1 SG 126893A1
Authority
SG
Singapore
Prior art keywords
peptides
immunogenicity
apr
immunogenic
cells
Prior art date
Application number
SG200602630A
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG126893A1 publication Critical patent/SG126893A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG200602630A 2005-04-20 2006-04-19 Method for the identification of epitopes related to immunogenicity in biopharmaceuticals SG126893A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
SG126893A1 true SG126893A1 (en) 2006-11-29

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200602630A SG126893A1 (en) 2005-04-20 2006-04-19 Method for the identification of epitopes related to immunogenicity in biopharmaceuticals

Country Status (8)

Country Link
US (1) US20060251664A1 (zh)
JP (1) JP4275144B2 (zh)
CN (1) CN1877336A (zh)
AT (1) ATE451618T1 (zh)
CA (1) CA2542104C (zh)
DE (1) DE602006010934D1 (zh)
ES (1) ES2334936T3 (zh)
SG (1) SG126893A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331714B2 (ja) * 2007-03-16 2013-10-30 コヴァルクス・アーゲー タンパク質複合体をターゲティングする薬物候補の直接質量分析
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
HUE060369T2 (hu) 2012-02-09 2023-02-28 Baylor College Medicine Peptidkeverékek széles spektrumú multivírus CTL-ek elõállítására
US10718781B2 (en) 2014-07-14 2020-07-21 Chugai Seiyaku Kabushiki Kaisha Method for identifying epitope on protein
US11167024B2 (en) 2015-09-18 2021-11-09 Baylor College Of Medicine Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
CN111548405A (zh) 2017-04-10 2020-08-18 伊玛提克斯生物技术有限公司 用于癌症免疫治疗的肽及其肽组合物
WO2018189148A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
MX2020012227A (es) * 2018-05-17 2021-04-13 Immunome Inc Epítopos marcadores del dominio ch3.
WO2024138754A1 (zh) * 2022-12-30 2024-07-04 深圳吉诺因生物科技有限公司 一种hla-a*11:01限制性抗原点替换方法、获得的多肽及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1405862B1 (en) * 2002-10-02 2008-04-09 F.Hoffmann-La Roche Ag Method for the identification of antigenic peptides

Also Published As

Publication number Publication date
DE602006010934D1 (de) 2010-01-21
US20060251664A1 (en) 2006-11-09
CA2542104C (en) 2010-12-07
JP4275144B2 (ja) 2009-06-10
CA2542104A1 (en) 2006-10-20
ATE451618T1 (de) 2009-12-15
CN1877336A (zh) 2006-12-13
ES2334936T3 (es) 2010-03-17
JP2006300945A (ja) 2006-11-02

Similar Documents

Publication Publication Date Title
SG126893A1 (en) Method for the identification of epitopes related to immunogenicity in biopharmaceuticals
WO2006046978A3 (en) Cationic peptide-mediated transformation
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
WO2009051555A3 (en) Modified mhc class i binding peptides
EP2534257A4 (en) METHOD OF IDENTIFYING AND ISOLATING CELLS FOR THE EXPRESSION OF POLYPEPTIDES
WO2009022154A3 (en) Peptide with multiple epitopes
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
IN2012DN02368A (zh)
ES2530777T3 (es) Vacunas peptídicas para cánceres que expresan antígenos asociados a tumores
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
WO2004063963A3 (en) Novel proteins with altered immunogenicity
MY170126A (en) Fc containing polypeptides with altered glycosylation and reduced effector function
EA200700136A1 (ru) Анти-cd154-антитела
NZ595707A (en) Cancer antigen helper peptide
EP2275435A3 (en) Streptococcus agalactiae antigens I + II
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2011153400A3 (en) Nasal immunization
EP4269562A3 (en) Antigen binding molecules and methods of use thereof
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
UA101142C2 (ru) Способ разработки антитела
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection
NZ591133A (en) Novel melanoma antigen peptide and uses thereof
Yu et al. Synthesis of a Glycopeptide Vaccine Conjugate for Induction of Antibodies Recognizing O‐Mannosyl Glycopeptides
WO2008010098A3 (en) Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
WO2002072606A3 (en) Epitope testing using hla